Sale of Neurocrine Group Limited - Assets And Liabilities Classified as Held For Sale (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - Neurocrine Group Limited $ in Millions |
Dec. 31, 2025
USD ($)
|
|---|---|
| Assets held for sale: | |
| Intangible assets, net | $ 29.8 |
| Other assets | 13.0 |
| Total assets held for sale included in other current assets | 42.8 |
| Liabilities related to assets held for sale: | |
| Accounts payable and accrued liabilities | 6.8 |
| Other liabilities | 1.4 |
| Total liabilities related to assets held for sale included in other current liabilities | $ 8.2 |
| X | ||||||||||
- Definition Amount classified as assets attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount classified as other assets attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount classified as other liabilities attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount classified as liabilities attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|